Article info
PDFOriginal research
Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group
- Correspondence to Professor Pauline Wimberger, Gynecology and Obstetrics, Technische Universitat Dresden Medizinische Fakultat Carl Gustav Carus, Dresden 01307, Germany; pauline.wimberger{at}uniklinikum-dresden.de
Citation
Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group
Publication history
- Received December 16, 2022
- Accepted March 13, 2023
- First published March 31, 2023.
Article Versions
- You are currently viewing a Previous version of this article (3 July 2023).
- Previous version (3 July 2023).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.